Pacific Shuanglin Bio pharmacy Co Ltd Financial Flexibility Index
Pacific Shuanglin Bio pharmacy Co Ltd financial flexibility index. Pacific Shuanglin Bio pharmacy Co Ltd (000403) has a Financial Flexibility Index of 0.09x as of September 2025. Free cash flow of CN¥142.45 Million (operating CF CN¥70.28 Million minus capex CN¥72.17 Million) represents 0% of total liabilities (CN¥1.55 Billion). Explore reinvestment intensity of Pacific Shuanglin Bio pharmacy Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Pacific Shuanglin Bio pharmacy Co Ltd (1998–2025)
Financial flexibility index of Pacific Shuanglin Bio pharmacy Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Pacific Shuanglin Bio pharmacy Co Ltd across 28 annual periods. Check total reinvestment intensity of Pacific Shuanglin Bio pharmacy Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Pacific Shuanglin Bio pharmacy Co Ltd Financial Flexibility Index by Year (1998–2025)
Pacific Shuanglin Bio pharmacy Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Pacific Shuanglin Bio pharmacy Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Pacific Shuanglin Bio pharmacy Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.08x | CN¥117.41 Million | CN¥-215.99 Million | CN¥1.39 Billion | ▼ -86.6% |
| 2024 | 0.63x | CN¥842.50 Million | CN¥321.79 Million | CN¥1.33 Billion | ▼ -27.5% |
| 2023 | 0.87x | CN¥1.06 Billion | CN¥679.01 Million | CN¥1.21 Billion | ▲ +8.5% |
| 2022 | 0.81x | CN¥902.86 Million | CN¥524.22 Million | CN¥1.12 Billion | ▼ -16.7% |
| 2021 | 0.97x | CN¥734.38 Million | CN¥408.22 Million | CN¥760.07 Million | ▲ +181.9% |
| 2020 | 0.34x | CN¥235.02 Million | CN¥194.84 Million | CN¥685.71 Million | ▼ -30.5% |
| 2019 | 0.49x | CN¥231.96 Million | CN¥190.84 Million | CN¥470.04 Million | ▲ +127.2% |
| 2018 | 0.22x | CN¥151.65 Million | CN¥116.63 Million | CN¥698.08 Million | ▲ +4079.0% |
| 2017 | 0.01x | CN¥3.96 Million | CN¥-35.91 Million | CN¥761.70 Million | ▼ -97.7% |
| 2016 | 0.23x | CN¥160.52 Million | CN¥62.49 Million | CN¥696.41 Million | ▲ +31.5% |
| 2015 | 0.18x | CN¥129.70 Million | CN¥70.31 Million | CN¥739.82 Million | ▼ -13.0% |
| 2014 | 0.20x | CN¥148.09 Million | CN¥77.04 Million | CN¥735.16 Million | ▼ -33.7% |
| 2013 | 0.30x | CN¥254.00 Million | CN¥91.01 Million | CN¥835.47 Million | ▼ -21.8% |
| 2012 | 0.39x | CN¥303.53 Million | CN¥123.24 Million | CN¥780.27 Million | ▲ +29.5% |
| 2011 | 0.30x | CN¥203.72 Million | CN¥130.14 Million | CN¥678.06 Million | ▲ +322.4% |
| 2010 | 0.07x | CN¥46.34 Million | CN¥9.88 Million | CN¥651.42 Million | ▼ -56.5% |
| 2009 | 0.16x | CN¥182.16 Million | CN¥111.86 Million | CN¥1.11 Billion | ▲ +43.2% |
| 2008 | 0.11x | CN¥118.49 Million | CN¥74.90 Million | CN¥1.04 Billion | ▲ +85.9% |
| 2007 | 0.06x | CN¥101.34 Million | CN¥95.03 Million | CN¥1.65 Billion | ▲ +3801.9% |
| 2006 | 0.00x | CN¥-2.88 Million | CN¥-10.42 Million | CN¥1.73 Billion | ▼ -105.8% |
| 2005 | 0.03x | CN¥56.01 Million | CN¥49.06 Million | CN¥1.97 Billion | ▲ +216.0% |
| 2004 | -0.02x | CN¥-37.09 Million | CN¥-131.73 Million | CN¥1.51 Billion | ▼ -132.8% |
| 2003 | 0.07x | CN¥104.70 Million | CN¥-49.47 Million | CN¥1.40 Billion | ▼ -77.0% |
| 2002 | 0.32x | CN¥248.27 Million | CN¥159.18 Million | CN¥765.52 Million | ▲ +12.4% |
| 2001 | 0.29x | CN¥199.24 Million | CN¥111.28 Million | CN¥690.82 Million | ▲ +98.9% |
| 2000 | 0.14x | CN¥83.98 Million | CN¥27.36 Million | CN¥579.29 Million | ▲ +9.6% |
| 1999 | 0.13x | CN¥63.35 Million | CN¥-23.08 Million | CN¥478.92 Million | ▲ +344.3% |
| 1998 | 0.03x | CN¥8.58 Million | CN¥-2.65 Million | CN¥288.28 Million | — |